Skip to content
Extreme Investor Network
  • Contact Us
  • Privacy Policy

Eli

Eli Lilly’s Earnings: Unpredictable for Traders Despite Momentum of Obesity Drug

April 30, 2024
Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says 

Are you looking to stay informed on the latest developments in the world of investing? Look no further than Extreme Investor Network, where we provide unique insights and valuable information that you won’t find anywhere … Read more

Categories Investing Tags drug, earnings, Eli, Lillys, Momentum, Obesity, traders, unpredictable

Federal Reserve Meeting and Earnings Reports from Apple, Amazon, and Eli Lilly

April 26, 2024
Fed meeting and Apple, Amazon, Eli Lilly report

Welcome to Extreme Investor Network, where we provide expert insights into all things money. Today, we’re diving into CNBC’s Jim Cramer’s analysis of what to expect on Wall Street next week. From earnings reports to … Read more

Categories Mad Money Tags amazon, Apple, earnings, Eli, Federal, Lilly, Meeting, Reports, Reserve

In sleep apnea trials, Eli Lilly’s weight loss drug Zepbound shows effectiveness

April 17, 2024
Eli Lilly weight loss drug Zepbound effective in sleep apnea trials

Introducing Zepbound: Eli Lilly’s Breakthrough Weight Loss Drug Offers Hope for Sleep Apnea Patients Eli Lilly made waves in the pharmaceutical industry when it announced that its highly popular weight loss drug Zepbound has shown … Read more

Categories Business News Tags apnea, drug, effectiveness, Eli, Lillys, loss, shows, sleep, trials, weight, Zepbound

Shortage of Eli Lilly’s Zepbound and Mounjaro confirmed by FDA until June

April 17, 2024
Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says 

As we delve into the world of pharmaceuticals, one hot topic that has recently come to light is the shortage of Eli Lilly’s popular weight loss drug, Zepbound, and its diabetes counterpart, Mounjaro. According to … Read more

Categories Business News Tags confirmed, Eli, FDA, June, Lillys, Mounjaro, Shortage, Zepbound

The FDA approval for Eli Lilly’s Alzheimer’s drug has been delayed.

March 18, 2024
Eli Lilly Alzheimer's drug FDA approval delayed

The pharmaceutical industry is abuzz with news of a potential breakthrough in the treatment of Alzheimer’s disease. Eli Lilly & Co. recently announced that its experimental drug, donanemab, showed promising results in slowing the progression … Read more

Categories Business News Tags Alzheimers, Approval, delayed, drug, Eli, FDA, Lillys
Newer posts
← Previous Page1 … Page6 Page7

Categories

Recent Posts

  • One Energy Stock Currently Offering a Dividend Yield Exceeding 7%June 14, 2025
  • US Dollar Outlook: DXY Surges as Crude Oil Developments Drive Safe-Haven DemandJune 14, 2025
  • Israel-Iran Conflicts and Two Key Factors Influencing the Stock Market This WeekJune 14, 2025
  • Five Stocks Poised for Growth, According to Goldman SachsJune 14, 2025
  • NVIDIA Unveils High-Performance FlashInfer for Optimized LLM InferenceJune 14, 2025
  • Coinbase and Shopify Collaborate on USDC Payment SolutionsJune 14, 2025
  • Despite Today’s News, the Semiconductor Index Remains on Course for $5700June 14, 2025
  • These Stocks, Oracle Included, Top Wall Street’s Overbought ListJune 14, 2025
  • REJKT.XYZ: Discover a New Era of Art on TezosJune 14, 2025
  • Gold Rises as Middle East Tensions EscalateJune 14, 2025

Archives

© 2025 Extreme Investor Network

Usermaven | Website analytics and product insights